Biotech in China - Assessing Market Opportunities for European SMEs
13 June 2024; 10:00 - 12:00 CEST
Online
Organizer: EU SME Centre

Subject: The biotech sector in China is booming. With supportive policies towards biotech development and a massive patient base, China can present a relevant opportunity for smaller European companies looking to scale up. Participating in this market can not only open doors to extensive R&D resources and potential partnerships. It can also provide SMEs with the chance to establish a foothold in one of the world’s fastest-growing biotech ecosystems.

However, entering the market involves navigating a set of complex risks, including on IPR protection. The competitive landscape is intense, with domestic companies often receiving strong governmental support, which can place foreign entrants at a disadvantage.

Speakers:

Hamish King (CEO, Cisema), Toby Mak (Patent Attorney, China IP SME Helpdesk)